| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 5,206,000 | 4,857,000 | 4,880,000 | 4,970,000 | | Cost of Revenue | 324,000 | 392,000 | 425,000 | 458,000 | | | Gross Profit | 4,882,000 | 4,465,000 | 4,455,000 | 4,512,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,871,000 | 1,960,000 | 1,823,000 | 1,835,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,869,000 | 1,520,000 | 1,159,000 | 659,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,142,000 | 985,000 | 1,473,000 | 2,018,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,142,000 | 985,000 | 1,473,000 | 2,018,000 | | Interest Expense | 496,000 | 628,000 | 699,000 | 682,000 | | Income Before Tax | 646,000 | 357,000 | 774,000 | 1,336,000 | | Income Tax Expense | 101,000 | 27,000 | 198,000 | 386,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 545,000 | 330,000 | 576,000 | 950,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 545,000 | 330,000 | 576,000 | 950,000 | | Preferred Stock And Other Adjustments | (16,000) | (70,000) | (19,000) | (22,000) | | | Net Income Applicable To Common Shares | $529,000 | $260,000 | $557,000 | $928,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
